SEI Investments
IGMS

SEI Investments’s IGM Biosciences IGMS Stock Holding History

SEI Investments’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,505
Closed -$208K – 2593
2021
Q2 		$208K Buy
+2,505
New +$186K ﹤0.01% 2433
2020
Q4 		– Sell
-2,920
Closed -$216K – 2491
2020
Q3 		$216K Buy
+2,920
New +$173K ﹤0.01% 2211

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SEI Investments's IGMS Position: Q3 2021 in Review

SEI Investments sold out of IGM Biosciences (IGMS) in Q3 2021, closing a stake of 2,505 shares — an estimated $208K sold.

SEI Investments first reported a position in IGMS in Q3 2020 and held it in 2 quarters. The position peaked at $216K in Q3 2020. 107 funds tracked by Wall St. Rank hold IGMS as of Q3 2021.

  • SEI Investments reported no remaining IGM Biosciences position as of Q3 2021 after selling out during the quarter.
  • SEI Investments sold 2,505 IGM Biosciences shares in Q3 2021, an estimated $208K.
  • SEI Investments first reported a position in IGM Biosciences in Q3 2020 and held it in 2 quarters.
  • SEI Investments's IGM Biosciences position peaked at $216K in Q3 2020.
  • 107 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2021.

Based on SEI Investments's 13F filing for Q3 2021, filed 12 Nov 2021.